CARLOS ALBAN

CIK 1474632 · Vice Chairman · last filed 2026-05-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$35.38M

Companies

4

Total Filings

58

Lifetime Open-Market Net

-$46.34M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Solventum Corp (SOLVw) Delisted Director 8,947 $0 6 2026-05-18
SpringWorks Therapeutics, Inc. (SWTX) Delisted Director 0 $46.99 $0 $0 5 2025-07-02
ABBV Vice Chairman 155,341 $227.73 $35.38M -$40.92M 23 2020-11-18
ABBOTT LABORATORIES (ABTw) Delisted Senior Vice President 136,138 -$5.42M 24 2012-12-04

Recent Filings · Page 3 of 6

58 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-05-08 ABBV Sell (S) −43,000 -$2.88M EDGAR
2017-03-02 ABBV Tax (F) −34,721 -$2.16M EDGAR
2017-02-21 ABBV Grant (A) +43,022 $0 EDGAR
2016-05-12 ABBV Sell (S) −47,438 -$3.01M EDGAR
2016-03-02 ABBV Tax (F) −39,930 -$2.24M EDGAR
2016-02-22 ABBV Grant (A) $0 EDGAR
2015-03-03 ABBV Tax (F) −19,906 -$1.20M EDGAR
2015-02-23 ABBV Grant (A) +51,580 $0 EDGAR
2014-03-04 ABBV Mixed −18,201 -$924.2K EDGAR
2014-02-24 ABBV Grant (A) +47,260 $0 EDGAR
Showing 2130 of 58
Page 3 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.